Skip to main content

Table 1 Patients demographic and perioperative data

From: Surgical treatment on infective endocarditis: impact of diabetes on mortality

  Group I (Not-DM patients) Group II (DM patients) p Value
N 326 94  
Age (years) 54.8 ± 16.1 66.4 ± 11.1 0.000
Male gender (n, %) 214 (65.6%) 61 (64.9%) 0.902
NIHA III-IV (n, %) 103 (31.6%) 37 (39.4%) 0.234
Previous cardiac surgery (n, %) 124 (38.0%) 36 (38.3%) 1.000
Native valve endocarditis (n, %) 212 (65.0%) 62 (66.0%) 0.903
EF (%) 54.6 ± 15.1 54.8 ± 15.9 0.914
Hypertension (n, %) 136 (42.0%) 76 (81.7%) 0.000
COPD (n, %) 15 (4.6%) 10 (10.8%) 0.044
Dialysis (n, %) 6 (2.1%) 5 (6.5%) 0.057
Hyperlipidemia (n, %) 100 (31.0%) 77 (81.9%) 0.000
PVD (n, %) 7 (2.2%) 12 (13.5%) 0.000
CVA/TIA (n, %) 46 (14.7%) 17 (18.5%) 0.414
Pulmonary hypertension (n, %) 40 (12.9%) 13(14.6%) 0.723
Smoking (n, %) 81 (25.3%) 35 (38.5%) 0.017
Standard EuroSCORE I 7.4 ± 3.9 10.0 ± 4.1 0.000
Logistic EuroSCORE % 16.3 ± 17.7 27.3 ± 24.4 0.000
Bypass time (min) 121.7 ± 56.1 148.8 ± 68.1 0.001
Cross-clamp (min) 86.1 ± 37.6 108.5 ± 48.3 0.000
Aortic valve involvement (n, %) 172 (52.8%) 55 (58.5%) 0.349
Mitral valve involvement (n, %) 175 (53.7%) 54 (57.4%) 0.558
Tricuspid valve involvement (n, %) 2 (0.6%) 0 (0%) 0.280
Annular reconstruction (n, %) 44 (13.5%) 21 (22.3%) 0.023
Concomitant procedure (n, %) 128 (39.3%) 54 (57.4%) 0.434